Overall Score

Financial Health

Liquidity remains adequate with a current ratio of 1.73 and quick ratio of 1.60.

Leverage appears manageable, with debt-to-equity at 0.73 and debt-to-assets at 0.30.

Cash generation remains weak, with negative operating cash flow and free cash flow TTM.

Profitability

Margins remain deeply negative, with EBIT margin at -1.52 and net margin at -1.53.

Returns on capital remain negative, including ROIC at -0.97 and ROE at -1.18.

Gross margin is only 6.5%, indicating limited pricing power or cost absorption.

Valuation

The stock trades at a modest EV/Sales multiple of 1.95, which is not demanding for a hardware/tech name.

Price-to-sales at 1.76 and price-to-book at 1.50 suggest the market is not pricing in strong growth.

Negative earnings and cash flow multiples limit the usefulness of traditional valuation metrics.

Growth

Revenue per share is low at 0.24, reflecting a still-small revenue base.

High R&D intensity at 1.07x revenue supports product development but also pressures near-term profitability.

No fresh news or updated growth catalysts were provided this month.